0

Journal Articles

in Multiple Sclerosis/Demyelinating Disease
 1-20 of 24 Articles
Lab Reports |  February 06, 2013
Restoring the Blood-Brain Barrier
Tracy Hampton, PhD
JAMA. 2013;309(5):431. doi:10.1001/jama.2013.267.
Health Agencies Update |  December 26, 2012
Tackling Autoimmunity
Bridget M. Kuehn, MSJ
JAMA. 2012;308(24):2557. doi:10.1001/jama.2012.156146.
Viewpoint |  September 05, 2012
The Safety Risks of Innovation:  The FDA's Expedited Drug Development Pathway
Thomas J. Moore, AB; Curt D. Furberg, MD, PhD
JAMA. 2012;308(9):869-870. doi:10.1001/jama.2012.9658.
Editorial |  July 18, 2012
Evaluating the Potential Benefit of Interferon Treatment in Multiple Sclerosis
Tobias Derfuss, MD; Ludwig Kappos, MD
JAMA. 2012;308(3):290-291. doi:10.1001/jama.2012.8327.
Health Agencies Update |  June 27, 2012
Fingolimod Precautions
Bridget M. Kuehn
JAMA. 2012;307(24):2578. doi:10.1001/jama.2012.7064.
Medical News and Perspectives |  June 27, 2012
FDA Warns About the Risks of Unproven Surgical Therapy for Multiple Sclerosis
Bridget M. Kuehn
JAMA. 2012;307(24):2575-2576. doi:10.1001/jama.2012.6399.
Health Agencies Update |  September 28, 2011
Myelination Process Examined
Bridget M. Kuehn
JAMA. 2011;306(12):1315. doi:10.1001/jama.2011.1379.
Medical News & Perspectives |  March 02, 2011
Scientists Probe Strategies to Repair Neuron Damage in Multiple Sclerosis
Bridget M. Kuehn
JAMA. 2011;305(9):871-874. doi:10.1001/jama.2011.208.
JAMA Patient Page |  January 19, 2011 FREE
Guillain-Barré Syndrome
Ryszard M. Pluta, MD, PhD; Cassio Lynm, MA; Robert M. Golub, MD
JAMA. 2011;305(3):319. doi:10.1001/jama.305.3.319.
INCLUDES: , Supplemental Content
Lab Reports |  May 05, 2010
UV Light and MS
M. J. Friedrich
JAMA. 2010;303(17):1686. doi:10.1001/jama.2010.527.
The World in Medicine |  February 17, 2010
Prions Illuminated
Joan Stephenson, PhD
JAMA. 2010;303(7):603. doi:10.1001/jama.2010.149.
The World in Medicine |  December 17, 2008
Multiple Sclerosis Clue
Joan Stephenson, PhD
JAMA. 2008;300(23):2717. doi:10.1001/jama.2008.849.
Original Contribution |  December 20, 2006 FREE
Serum 25-Hydroxyvitamin D Levels and Risk of Multiple Sclerosis
Kassandra L. Munger, MSc; Lynn I. Levin, PhD, MPH; Bruce W. Hollis, PhD; et al.
JAMA. 2006;296(23):2832-2838. doi:10.1001/jama.296.23.2832.
JAMA Patient Page |  December 20, 2006 FREE
Multiple Sclerosis
Sarah Ringold, MD; Cassio Lynm, MA; Richard M. Glass, MD
JAMA. 2006;296(23):2880. doi:10.1001/jama.296.23.2880.
INCLUDES: , Supplemental Content
From the Centers for Disease Control and Prevention |  June 14, 2006 FREE
Update: Guillain-Barré Syndrome Among Recipients of Menactra® Meningococcal Conjugate Vaccine—United States, October 2005–February 2006
JAMA. 2006;295(22):2596-2597. doi:10.1001/jama.295.22.2596.
Original Contribution |  May 25, 2005 FREE
Temporal Relationship Between Elevation of Epstein-Barr Virus Antibody Titers and Initial Onset of Neurological Symptoms in Multiple Sclerosis
Lynn I. Levin, PhD, MPH; Kassandra L. Munger, MSc; Mark V. Rubertone, MD, MPH; et al.
JAMA. 2005;293(20):2496-2500. doi:10.1001/jama.293.20.2496.
Original Contribution |  January 26, 2005 FREE
Exposure to Infant Siblings During Early Life and Risk of Multiple Sclerosis
Anne-Louise Ponsonby, PhD; Ingrid van der Mei, PhD; Terence Dwyer, MD; et al.
JAMA. 2005;293(4):463-469. doi:10.1001/jama.293.4.463.
JAMA Patient Page |  January 26, 2005 FREE
Multiple Sclerosis
Sarah Ringold, MD; Cassio Lynm, MA; Richard M. Glass, MD
JAMA. 2005;293(4):514. doi:10.1001/jama.293.4.514.
Original Contribution |  September 10, 2003 FREE
Effect of Awareness of a Randomized Controlled Trial on Use of Experimental Therapy
William F. Clark, MD, FRCPC; Amit X. Garg, MD, FRCPC; Peter G. Blake, MB, FRCPC; et al.
JAMA. 2003;290(10):1351-1355. doi:10.1001/jama.290.10.1351.
Editorial |  December 26, 2001
Viruses and Multiple Sclerosis
Donald H. Gilden, MD
JAMA. 2001;286(24):3127-3129. doi:10.1001/jama.286.24.3127.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Neurology
Original Contribution  |  May 6, 2013
Genetic Analysis of Inherited Leukodystrophies:  Genotype-Phenotype Correlations in the CSF1R Gene
Rita Guerreiro, PhD; Eleanna Kara, MD, MSc; Isabelle Le Ber, MD, PhD; et al.
JAMA Neurology
Correspondence  |  May 01, 2013
Interferon Beta and Long-term Disability in Multiple Sclerosis
Afsaneh Shirani, MD; Yinshan Zhao, PhD; Mohammad Ehsanul Karim, MSc; et al.
JAMA Neurology
Correspondence  |  May 01, 2013
Interferon Beta and Long-term Disability in Multiple Sclerosis—Reply
Benjamin M. Greenberg, MD, MHS; Elliot Frohman, MD, PhD
JAMA Neurology
Original Contribution  |  March 25, 2013
Central Veins in Brain Lesions Visualized With High-Field Magnetic Resonance Imaging:  A Pathologically Specific Diagnostic Biomarker for Inflammatory Demyelination in the Brain
Niraj Mistry, MA; Jennifer Dixon, PhD; Emma Tallantyre, PhD; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems